685536-12-3

Basic information

• Product Name: Benzenamine, 2-bromo-5-chloro-4-methoxy-
• CAS NO: 685536-12-3
• Molecular Formula: C7H7BrClNO
• Molecular Weight: 236.496
• Mol File: 685536-12-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzenamine, 2-bromo-5-chloro-4-methoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenamine, 2-bromo-5-chloro-4-methoxy-(685536-12-3)
• EPA Substance Registry System: Benzenamine, 2-bromo-5-chloro-4-methoxy-(685536-12-3)

Safety Data

• Hazardous Substances Data: 685536-12-3(Hazardous Substances Data)

Upstream product

• 5345-54-0 3-chloro-4-methoxyaniline 

Downstream Products

• 1262881-25-3 N-(2-bromo-5-chloro-4-methoxyphenyl)-2,2,2-trifluoroacetamide 
• 1262881-61-7 6-chloro-5-methoxy-2-phenyl-1H-indole 
• 868406-56-8 1-(5-chloro-2-{(E)-3-[3-(4-fluorobenzyl)-3,8-diazabicyclo[3.2.1]oct-8-yl]-3-oxopropenyl}-4-methoxyphenyl)-3-methylurea 
• 868406-59-1 (E)-(5-chloro-2-{3-[3-(4-fluorobenzyl)-3,8-diazabicyclo[3.2.1]oct-8-yl]-3-oxopropenyl}-4-methoxyphenyl)-urea 
• 868406-57-9 (E)-3-(2-amino-4-chloro-5-methoxyphenyl)-acrylic acid 
• 868406-58-0 (E)-3-(2-amino-4-chloro-5-methoxyphenyl)-1-[3-(4-fluorobenzyl)-3,8-diazabicyclo[3.2.1]oct-8-yl]-propenone 
• 685534-98-9 3-[2-(acetylamino)-4-chloro-5-methoxyphenyl]-2-(2E)-propenoic acid 
• 1616295-96-5 C₁₂H₁₅BrClNO₃ 
• 1616295-97-6 2-tert-butoxycarbonylamino-4-chloro-5-methoxy-benzoic acid 
• 685536-52-1 3-(2-bromo-5-chloro-4-methoxy-phenyl)-5,5-dimethyl-imidazolidine-2,4-dione 
• 685535-00-6 (E)-3-(2-amino-4-chloro-5-methoxyphenyl)-acryclic acid ethyl ester 
• 685536-21-4 (2-bromo-5-chloro-4-methoxy-phenyl)-urea 

Relevant articles and documents

SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1

Provided herein are small molecule neurotensin receptor agonists, compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.

1-(4-BENZYL-PIPERAZIN-1-YL)-3-PHENYL-PROPENONE DERIVATIVES

A compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, wherein the symbols have meaning as defined, which are antagonists of CCR-1 and which find use pharmaceutically for treatment of diseases and conditions in which CCR-1 is i